Novartis Pharmaceuticals Corp. Director, US Diversity & Inclusion During his career, Ben has held various sales, account management, and leadership roles at Procter & Gamble Pharmaceuticals, Bristol Myers Squibb, Roche Labs, Sanofi Genzyme and most recently, Novartis. (more ...) His prior appointments have been as the Head of Multicultural Marketing for Sanofi Genzyme’s Diabetes & Cardiovascular franchises before joining Novartis in 2018 as an Associate Director for the Cardio-Renal Metabolism Systems of Care team in the Northern New Jersey and NY City market. He currently serves as the US Director for Diversity & Inclusion and is the D&I Lead for Disparities in Care for Novartis. Throughout his three-decade career, Ben has been recognized as a champion for underrepresented communities for his quality initiatives projects in collaboration with healthcare systems. He has been vocal in facilitating and participating in courageous conversations on diversity and inclusion throughout Novartis in light of the racial challenges faced in the US and the impact implicit bias and racism has had in the field of medicine. Ben is a native son of New York City and a graduate of Pace University. In 2012, he earned the distinction of Certified Professional in Health Care Quality (CPHQ) from the National Association of Healthcare Quality and received his certification as a Lean Six Sigma Green Belt (LSSGB). He is a former Board Member of the Hispanic AIDS Forum and supporter of The Latino Commission on AIDS. In his spare time, he advocates for at risk youth in the LGBTQI community and works to raise awareness of bile duct cancer by partnering with the Cholangiocarcinoma Foundation of America. Ben’s pronouns are he/him/his and he currently resides in New York City with his husband, Jordan. HEC member category Industry
